Véronique brings over 20 years of experience in Business Development and Alliance Management across the healthcare spectrum including pharma, biotech, medtech, e-health and academics.
At Ipsen, Véronique oversees all global business development efforts bringing innovative medicines and novel platforms to augment Ipsen’s pipeline in Oncology, Rare Diseases and Neurosciences. Veronique is also managing the Strategic Alliance Management team to ensure the successful implementation of global strategic partnerships throughout their entire lifecycle.
Prior to joining Ipsen, Véronique was VP of R&D Business Development at Takeda, responsible with her team for establishing partnerships to support GI and Regenerative Medicine as well as overseeing all out-bound transactions for Takeda's R&D assets.
Prior to Takeda held various BD, M&A and Alliance Management roles of increasing responsibilities at Pfizer, Teva, BMS and Monsanto both in U.S. and Europe.
Véronique also served as Observer on iCardiac, Aviir and Portal Instruments ‘s Board of Directors
Véronique holds a BS and a MS in Economics from Université Libre de Bruxelles (ULB), Belgium.